Taletrectinib Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 200 mg
Reference Brands: Ibtrozi (USA)
Category: Oncology Cancer Care
Taletrectinib is a next-generation tyrosine kinase inhibitor that targets ROS1 and NTRK fusion proteins. It is used to treat adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer. It works by blocking the abnormal ROS1 signaling that drives cancer cell growth and proliferation. Because it is taken once daily, on an empty stomach (2 hours before or after food), it has specific administration requirements. Taletrectinib is available in Capsules and strengths such as 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Taletrectinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Taletrectinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Taletrectinib is used to treat adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that has a ROS1 gene fusion. It helps slow or stop the growth of cancer cells by blocking ROS1 and certain NTRK pathways.
Taletrectinib is a small-molecule kinase inhibitor formulated as taletrectinib adipate. It works by inhibiting ROS1 and NTRK receptors that drive the growth of certain cancer cells.
The trade name is Ibtrozi.
It is developed and marketed by Nuvation Bio along with partnered manufacturers for distribution.
The generic name is taletrectinib, commonly available as taletrectinib adipate.
The brand name is Ibtrozi.
It is manufactured in authorized facilities in the United States and partner regions for global supply.
Related Products
Momelotinib
Strength:
100 mg, 150 mg, 200 mg
Form: Tablets
Reference Brands: Ojjaara (USA)
View Details
Nirogacestat
Strength:
50 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Nintedanib
Strength:
100 mg, 150 mg
Form: Capsules
Reference Brands: Ofev (USA, EU), Vargatef (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
